Pratia Brno s.r.o.

The gastroenterology unit at Pratia Brno s.r.o. runs trials focused on Crohn’s disease and ulcerative colitis, aiming to test new therapies and assess clinical remission and endoscopic response.

• Evaluation of novel oral and intravenous agents for induction of remission
• Head‑to‑head comparison with established biologics
• Use of stool frequency, abdominal pain, and endoscopic scores as outcome measures

With 24 active studies and 15 investigators, the site provides a strong platform for advancing digestive health research.

Clinical work includes autoimmune skin conditions such as atopic dermatitis and psoriasis, where the goal is to evaluate efficacy and long‑term safety of biologic and small‑molecule treatments.

• Safety profiling of long‑term biologic therapies
• Head‑to‑head efficacy comparisons of new agents versus standard care
• Biomarker‑driven assessment of treatment response

The department collaborates with European regulatory agencies to align trial designs with international standards.

Studies target joint and bone disorders including knee osteoarthritis, low back pain, and postmenopausal osteoporosis, with the purpose of reducing pain, improving function, and preserving bone density.

• Dose‑response characterization of novel analgesics for chronic pain
• Evaluation of adjunctive diet‑exercise programs for weight‑related joint disease
• Bone mineral density outcomes with biosimilar anti‑resorptive agents

Multidisciplinary assessment within the gastroenterology clinic supports comprehensive musculoskeletal care.

The site conducts migraine research, focusing on migraine prevention with injectable and oral therapies to lower monthly migraine days and improve quality of life.

• Placebo‑controlled efficacy of botulinum toxin formulations
• Single‑cycle safety of novel CGRP antagonists
• Comparative studies of chronic versus episodic migraine populations

Expertise in chronic pain management enhances the robustness of neurological trial outcomes.

Research addresses metabolic health, particularly obesity and overweight, often in conjunction with musculoskeletal comorbidities, to evaluate weight‑loss efficacy and its impact on joint symptoms.

• Primary endpoint of percent body‑weight change
• Combination of pharmacologic therapy with lifestyle counseling
• Assessment of osteoarthritis pain improvement alongside weight reduction

Integrated care pathways allow simultaneous monitoring of metabolic and digestive health.

Trials focus on inflammatory skin disorders such as moderate‑to‑severe plaque psoriasis, investigating efficacy, safety, and patient‑reported outcomes of new oral and injectable agents.

• Long‑term tolerability of oral JAK inhibitors
• Comparative effectiveness of biosimilar versus reference biologics
• Real‑world quality‑of‑life assessments in treated patients

Dermatologic expertise complements the gastroenterology department’s systemic inflammation focus.

Research explores physiological mechanisms linking musculoskeletal and neural systems in chronic pain, aiming to identify biomarkers and novel therapeutic targets.

• Biomarker analysis of pain pathways and central sensitization
• Neuro‑muscular function testing in patients with low back pain
• Exploratory studies of neural modulation techniques for chronic musculoskeletal conditions

Findings inform cross‑disciplinary treatment strategies at Pratia Brno s.r.o..